These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14599020)

  • 41. D-dihexanoylphosphatidylcholine is not a pure competitive inhibitor of phospholipase A2 hydrolysis of L-dihexanoylphosphatidylcholine.
    Kanda P; Wells MA
    Chem Phys Lipids; 1985; 37(3):251-6. PubMed ID: 4042254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex.
    Bennion C; Connolly S; Gensmantel NP; Hallam C; Jackson CG; Primrose WU; Roberts GC; Robinson DH; Slaich PK
    J Med Chem; 1992 Aug; 35(16):2939-51. PubMed ID: 1501221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
    Seno K; Okuno T; Nishi K; Murakami Y; Yamada K; Nakamoto S; Ono T
    Bioorg Med Chem Lett; 2001 Feb; 11(4):587-90. PubMed ID: 11229777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition.
    Murelli RP; Cheung AK; Snapper ML
    J Org Chem; 2007 Mar; 72(5):1545-52. PubMed ID: 17315974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.
    Cordella-Miele E; Miele L; Mukherjee AB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10290-4. PubMed ID: 7694288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective C-glycosidation of D-fucose derivatives directed by the protective groups.
    Cortezano-Arellano O; Meléndez-Becerra CA; Cortés F; Sartillo-Piscil F; Cordero-Vargas A
    Carbohydr Res; 2014 Jul; 393():51-9. PubMed ID: 24893263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2.
    Boyd HF; Hammond B; Hickey DM; Ife RJ; Leach CA; Lewis VA; Macphee CH; Milliner KJ; Pinto IL; Smith SA; Stansfield IG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2001 Mar; 11(5):701-4. PubMed ID: 11266173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.
    Lehr M
    J Med Chem; 1997 Oct; 40(21):3381-92. PubMed ID: 9341913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A small-molecule FRET probe to monitor phospholipase A2 activity in cells and organisms.
    Wichmann O; Wittbrodt J; Schultz C
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):508-12. PubMed ID: 16323228
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2.
    Lehr M
    J Med Chem; 1997 Aug; 40(17):2694-705. PubMed ID: 9276015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
    Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
    ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total synthesis of the bacterial RNA polymerase inhibitor ripostatin B.
    Glaus F; Altmann KH
    Angew Chem Int Ed Engl; 2012 Apr; 51(14):3405-9. PubMed ID: 22378713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
    Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
    Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel delta2-isoxazolines as group II phospholipase A2 inhibitors.
    Basappa ; Satish Kumar M; Nanjunda Swamy S; Mahendra M; Shashidhara Prasad J; Viswanath BS; Rangappa KS
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3679-81. PubMed ID: 15203142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rhodium-catalyzed intramolecular formation of N-sulfamoyl 2,3-aziridino-γ-lactones and their use for the enantiospecific synthesis of α,β-diamino acid derivatives.
    Valle MS; Saraiva MF; Retailleau P; de Almeida MV; Dodd RH
    J Org Chem; 2012 Jul; 77(13):5592-9. PubMed ID: 22667756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are phospholipid-binding proteins in vivo phospholipase inhibitors?
    Poensgen J
    Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WA8242A1, A2 and B, novel secretory phospholipase A2 inhibitors produced by Streptomyces violaceusniger. I. Taxonomy, production and purification.
    Yoshimura S; Otsuka T; Tsurumi Y; Muramatsu Y; Hatanaka H; Okamoto M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 1998 Jan; 51(1):1-7. PubMed ID: 9531980
    [No Abstract]   [Full Text] [Related]  

  • 60. Enantioselective total synthesis of (-)-dactylolide.
    Louis I; Hungerford NL; Humphries EJ; McLeod MD
    Org Lett; 2006 Mar; 8(6):1117-20. PubMed ID: 16524282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.